West Pharmaceutical Services, Inc. (NYSE:WST) Shares Sold by Allspring Global Investments Holdings LLC

Allspring Global Investments Holdings LLC decreased its holdings in shares of West Pharmaceutical Services, Inc. (NYSE:WST) by 8.1% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 3,687 shares of the medical instruments supplier’s stock after selling 326 shares during the period. Allspring Global Investments Holdings LLC’s holdings in West Pharmaceutical Services were worth $1,107,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of WST. Fidelis Capital Partners LLC purchased a new position in West Pharmaceutical Services during the first quarter worth $27,000. Crewe Advisors LLC boosted its holdings in shares of West Pharmaceutical Services by 322.7% during the second quarter. Crewe Advisors LLC now owns 93 shares of the medical instruments supplier’s stock worth $31,000 after purchasing an additional 71 shares during the last quarter. ORG Partners LLC grew its position in shares of West Pharmaceutical Services by 820.0% in the first quarter. ORG Partners LLC now owns 138 shares of the medical instruments supplier’s stock valued at $55,000 after purchasing an additional 123 shares during the period. Quest Partners LLC increased its stake in West Pharmaceutical Services by 5,633.3% in the second quarter. Quest Partners LLC now owns 172 shares of the medical instruments supplier’s stock valued at $57,000 after purchasing an additional 169 shares during the last quarter. Finally, Blue Trust Inc. boosted its stake in West Pharmaceutical Services by 332.1% in the 2nd quarter. Blue Trust Inc. now owns 242 shares of the medical instruments supplier’s stock worth $80,000 after buying an additional 186 shares during the last quarter. Institutional investors and hedge funds own 93.90% of the company’s stock.

Insider Buying and Selling at West Pharmaceutical Services

In other news, VP Charles Witherspoon sold 703 shares of the company’s stock in a transaction dated Tuesday, October 29th. The shares were sold at an average price of $310.40, for a total value of $218,211.20. Following the sale, the vice president now owns 1,253 shares in the company, valued at approximately $388,931.20. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.53% of the stock is owned by insiders.

West Pharmaceutical Services Price Performance

Shares of West Pharmaceutical Services stock opened at $307.90 on Friday. The stock has a market capitalization of $22.30 billion, a P/E ratio of 45.68, a PEG ratio of 23.68 and a beta of 1.01. The company has a current ratio of 3.00, a quick ratio of 2.23 and a debt-to-equity ratio of 0.07. The business’s fifty day moving average price is $301.40 and its 200 day moving average price is $320.19. West Pharmaceutical Services, Inc. has a twelve month low of $265.00 and a twelve month high of $413.70.

West Pharmaceutical Services (NYSE:WST) last announced its quarterly earnings results on Thursday, October 24th. The medical instruments supplier reported $1.85 earnings per share for the quarter, topping analysts’ consensus estimates of $1.50 by $0.35. The firm had revenue of $746.90 million during the quarter, compared to analysts’ expectations of $709.62 million. West Pharmaceutical Services had a net margin of 17.37% and a return on equity of 18.41%. The firm’s revenue was down .1% on a year-over-year basis. During the same period in the prior year, the company earned $2.16 EPS. As a group, research analysts anticipate that West Pharmaceutical Services, Inc. will post 6.55 earnings per share for the current year.

West Pharmaceutical Services Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, November 20th. Stockholders of record on Wednesday, November 13th will be given a dividend of $0.21 per share. This represents a $0.84 dividend on an annualized basis and a dividend yield of 0.27%. This is a positive change from West Pharmaceutical Services’s previous quarterly dividend of $0.20. The ex-dividend date of this dividend is Wednesday, November 13th. West Pharmaceutical Services’s payout ratio is presently 12.46%.

West Pharmaceutical Services Profile

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.